Neumora Therapeutics NMRA
NASDAQ NMRA
$0.68 -0.01 (-2.05%)
At close: Sep 29, 2026 · 4:00 PM EDT

Neumora Therapeutics (NMRA) Times Interest Earned (2025 - 2026)

Updated

Neumora Therapeutics' Times Interest Earned was -23.18 in Q2 2026, compared with -123.94 a year earlier.

Analysis

Neumora Therapeutics (NMRA) Times Interest Earned (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, Neumora Therapeutics' Times Interest Earned was -32.71 through Jun 30, 2026; for FY2025, it came in at -74.92.

  • Per Business Quant data, NMRA's Times Interest Earned in the three quarters before Q2 2026 was -28.51 (Q1 2026), -28.72 (Q4 2025) and -77.24 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 25.41
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 10.28
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 7.27
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 5.22
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -42.08
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Neumora Therapeutics 129.65 Mn 129.65 Mn - -23.18
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -23.18
Mar 31, 2026 -28.51
Dec 31, 2025 -28.72
Sep 30, 2025 -77.24
Jun 30, 2025 -123.94
API Access

Neumora Therapeutics Times Interest Earned API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=times-interest-earned&ticker=NMRA&period=max&api_key=YOUR_API_KEY